Bagsværd, Denmark, 24 July 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR), also referred to as the Safe Harbour rules. This programme is part of the overall share repurchase programme of up to DKK 16 billion to be executed during a 12-month period beginning 2 February 2017.
Under the programme initiated 3 May 2017, Novo Nordisk will repurchase B shares for an amount up to DKK 4.3 billion in the period from 3 May 2017 to 7 August 2017.
Further information
| Media: | ||
| Anne Margrethe Hauge | +45 4442 3450 | |
| Ken Inchausti (US) | +1 609 786 8316 | |
| Investors: | ||
| Peter Hugreffe Ankersen | +45 3075 9085 | |
| Hanna Ögren | +45 3079 8519 | |
| Anders Mikkelsen | +45 3079 4461 | |
| Kasper Veje (US) | +1 609 235 8567 |
Company announcement no. 56 / 2017
Company announcement No. 56 / 2017
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via GlobeNewswire
HUG#2122492